Gene delivery systems can target specific brain cells, a breakthrough that could lead to treatments for Parkinson's, Alzheimer's and other neurodegenerative diseases.

The European Union is open to lowering tariffs on U.S. fertiliser imports as an offer in trade talks with the Trump ...

Humans have spent thousands of years experimenting with weight loss aids. While Ozempic and Wegovy may be generating ...

Sanofi to acquire Blueprint Medicines for up to $9.5B to expand its rare immunological disease portfolio, including an ...

Dr. Eric Topol has been studying Super Agers for decades. Here’s how he changed his life based on what his research showed.

Drivers are legally obliged to inform the DVLA of any current or new medical conditions which may affect their driving ...

Sanofi to acquire Vigil Neuroscience, Inc., adding a new investigational medicine to treat Alzheimer's disease to the neurology pipeline Paris, May 22, 2025. Sanofi announced today that it has entered ...

The acquisition includes a rare immunology disease medicine, Ayvakit/Ayvakyt (avapritinib), approved in the US and the EU, and a promising advanced and early-stage immunology pipeline. Furthermore, ...

What we eat plays a major role in the health of the gut microbiome, and certain foods can harm your gut health. According to Chris Damman, MD, MA, a board-certified gastroenterologist at the ...

As CIDP moves toward targeted therapies and patient-friendly regimens, the market is primed for disruption—offering a fresh ...

Senate Republicans return to session with a big task ahead: passing Trump's big, "beautiful" bill. And, Boulder's Jewish ...